JP2011527560A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011527560A5 JP2011527560A5 JP2010544332A JP2010544332A JP2011527560A5 JP 2011527560 A5 JP2011527560 A5 JP 2011527560A5 JP 2010544332 A JP2010544332 A JP 2010544332A JP 2010544332 A JP2010544332 A JP 2010544332A JP 2011527560 A5 JP2011527560 A5 JP 2011527560A5
- Authority
- JP
- Japan
- Prior art keywords
- exemplify
- cytokines
- limited
- type
- further examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6202208P | 2008-01-22 | 2008-01-22 | |
| US6204508P | 2008-01-22 | 2008-01-22 | |
| US6201208P | 2008-01-22 | 2008-01-22 | |
| US61/062,022 | 2008-01-22 | ||
| US61/062,045 | 2008-01-22 | ||
| US61/062,012 | 2008-01-22 | ||
| US13391208P | 2008-07-03 | 2008-07-03 | |
| US61/133,912 | 2008-07-03 | ||
| US20389008P | 2008-12-30 | 2008-12-30 | |
| US61/203,890 | 2008-12-30 | ||
| PCT/US2009/000424 WO2009094172A2 (en) | 2008-01-22 | 2009-01-22 | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014094974A Division JP6309815B2 (ja) | 2008-01-22 | 2014-05-02 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011527560A JP2011527560A (ja) | 2011-11-04 |
| JP2011527560A5 true JP2011527560A5 (pt-PT) | 2012-03-15 |
| JP5542064B2 JP5542064B2 (ja) | 2014-07-09 |
Family
ID=40810017
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010544332A Expired - Fee Related JP5542064B2 (ja) | 2008-01-22 | 2009-01-22 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
| JP2014094974A Expired - Fee Related JP6309815B2 (ja) | 2008-01-22 | 2014-05-02 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
| JP2016114592A Pending JP2017002040A (ja) | 2008-01-22 | 2016-06-08 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
| JP2019031123A Pending JP2019123715A (ja) | 2008-01-22 | 2019-02-25 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
| JP2021016186A Pending JP2021073281A (ja) | 2008-01-22 | 2021-02-04 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014094974A Expired - Fee Related JP6309815B2 (ja) | 2008-01-22 | 2014-05-02 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
| JP2016114592A Pending JP2017002040A (ja) | 2008-01-22 | 2016-06-08 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
| JP2019031123A Pending JP2019123715A (ja) | 2008-01-22 | 2019-02-25 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
| JP2021016186A Pending JP2021073281A (ja) | 2008-01-22 | 2021-02-04 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US8853358B2 (pt-PT) |
| EP (2) | EP2245056B1 (pt-PT) |
| JP (5) | JP5542064B2 (pt-PT) |
| KR (7) | KR20180123731A (pt-PT) |
| CN (4) | CN111346213A (pt-PT) |
| AU (1) | AU2009206748B2 (pt-PT) |
| CA (1) | CA2712757A1 (pt-PT) |
| ES (1) | ES2539124T3 (pt-PT) |
| HK (2) | HK1143822A1 (pt-PT) |
| IL (1) | IL207155A (pt-PT) |
| MX (3) | MX2010008050A (pt-PT) |
| NZ (3) | NZ587105A (pt-PT) |
| PL (1) | PL2245056T4 (pt-PT) |
| SG (3) | SG188161A1 (pt-PT) |
| WO (1) | WO2009094172A2 (pt-PT) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007052154A2 (en) | 2005-04-29 | 2007-05-10 | University Of Medicine And Dentistry Of New Jersey | Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators |
| US9345745B2 (en) | 2005-04-29 | 2016-05-24 | Bo Wang | Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides |
| US9585932B2 (en) | 2005-04-29 | 2017-03-07 | Peter C. Dowling | Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders |
| PT2371855E (pt) | 2005-08-05 | 2015-11-03 | Araim Pharmaceuticals Inc | Péptidos protetores de tecidos e suas utilizações |
| WO2009094172A2 (en) | 2008-01-22 | 2009-07-30 | Araim Pharmaceuticals, Inc. | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| ES2773017T3 (es) | 2010-04-06 | 2020-07-09 | Synedgen Inc | Derivados de quitosano para el tratamiento de mucositis o ulceración |
| US9999702B2 (en) * | 2010-04-09 | 2018-06-19 | Kci Licensing Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
| US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
| US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
| WO2012069474A2 (en) | 2010-11-24 | 2012-05-31 | H. Lundbeck A/S | A method for reducing potential virus burden in a sample by cyanate treatment |
| EP2656079A2 (en) * | 2010-12-20 | 2013-10-30 | Universiteit Gent | Crystal structure of flt3 ligand-receptor complex |
| US9248198B2 (en) * | 2011-06-13 | 2016-02-02 | The Board Of Trustees Of The University Of Illinois | Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion |
| FR2978964B1 (fr) * | 2011-08-09 | 2015-02-20 | Conservatoire Nat Arts | Composition vaccinale anti-il-6 |
| CA2856329A1 (en) | 2011-11-17 | 2013-05-23 | Nencki Institute Of Experimental Biology | Compositions and methods for treating glioma |
| WO2014047506A1 (en) * | 2012-09-20 | 2014-03-27 | Synedgen, Inc. | Methods for treatment or prevention of damage resulting from radiation, trauma or shock |
| US9895399B2 (en) | 2013-01-31 | 2018-02-20 | The Trustees Of The University Of Pennsylvania | Repair of peripheral nerve injury |
| WO2014144095A2 (en) | 2013-03-15 | 2014-09-18 | The Board Of Regents Of The University Of Oklahoma | Compositions comprising d-amino acid peptides and methods of production and use thereof for inhibiting autoantibodies |
| US20160168199A1 (en) * | 2013-07-17 | 2016-06-16 | Araim Pharmaceuticals, Inc. | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| KR101510743B1 (ko) * | 2013-07-23 | 2015-04-10 | (주)케어젠 | 파골 세포 분화 억제용 펩타이드 및 이의 용도 |
| JP6573620B2 (ja) | 2014-02-10 | 2019-09-11 | フレッド ハッチンソン キャンサー リサーチ センター | 心臓発作及び虚血損傷のハロゲン治療 |
| CN108125965B (zh) * | 2014-04-25 | 2020-04-10 | 广州市赛普特医药科技股份有限公司 | 5α-雄甾-3β,5,6β-三醇及其类似物在高原病中的应用 |
| US9314457B2 (en) | 2014-06-19 | 2016-04-19 | The University Of Utah Research Foundation | Methods of treating and preventing vascular instability diseases |
| GB2539161A (en) * | 2014-11-26 | 2016-12-14 | Neuro-Bio Ltd | Neurodegenerative disorders |
| US20180292390A1 (en) * | 2015-04-23 | 2018-10-11 | Rowan University | Novel slice cultures and methods for diagnosing neuronal degeneration diseases |
| CN105233256A (zh) * | 2015-10-28 | 2016-01-13 | 中国人民解放军第三军医大学 | 促红细胞生成素及其衍生物在制备治疗疾病中促进凋亡细胞清除的药物中的应用 |
| RU2613308C1 (ru) * | 2015-11-23 | 2017-03-15 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Способ прогнозирования предрасположенности к послеоперационному кровотечению при раке головки поджелудочной железы |
| US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| WO2017189988A1 (en) * | 2016-04-29 | 2017-11-02 | Araim Pharmaceuticals, Inc. | Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage |
| CN106075392B (zh) * | 2016-07-18 | 2020-07-07 | 滨州医学院 | 促红细胞生成素衍生物在听力保护上的应用 |
| IL247369B (en) * | 2016-08-18 | 2018-08-30 | B G Negev Tech And Applications Ltd | Polypeptides derived from CSF-m and their uses |
| CA3035561A1 (en) * | 2016-09-02 | 2018-03-08 | Christopher J. Soares | Use of cgrp receptor antagonists in neuroprotection and neurological disorders |
| CA3042295A1 (en) * | 2016-11-10 | 2018-05-17 | Asc Regenity Ltd. | Cosmetic formulations for topical applications containing erythropoietin-derived molecules |
| JP2020509011A (ja) * | 2017-02-27 | 2020-03-26 | テグ キョンブク インスティトゥート オブ サイエンス アンド テクノロジー | エリスロポエチン由来ペプチドの細胞損傷防止に対する効果を介した活用 |
| JP6450999B2 (ja) * | 2017-03-31 | 2019-01-16 | 国立大学法人群馬大学 | Ｂ型ボツリヌス毒素を用いたレイノー現象の治療 |
| AU2018261021A1 (en) * | 2017-05-05 | 2019-12-12 | Trefoil Therapeutics, Inc. | Recombinant modified fibroblast growth factors and therapeutic uses thereof |
| CN110590919B (zh) * | 2017-05-24 | 2022-05-24 | 中国海洋大学 | 含鸟氨酸的短肽及其应用 |
| US11419951B2 (en) * | 2017-08-19 | 2022-08-23 | Ohio State Innovation Foundation | Peptide-based cancer imaging agents |
| US20200223894A1 (en) * | 2017-09-19 | 2020-07-16 | Auckland Uniservices Limited | Peptides for the treatment of conditions associated with adiponectin dysfunction |
| CN107880109B (zh) | 2017-11-01 | 2019-08-30 | 复旦大学附属中山医院 | 一种促红细胞生成素来源肽及其制备方法和用途 |
| US10975124B2 (en) | 2018-02-23 | 2021-04-13 | The Board Of Regents Of The University Of Oklahoma | Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor |
| KR102167641B1 (ko) | 2018-08-27 | 2020-10-19 | 주식회사 사이루스 | 에리스로포이에틴 유래 펩티드를 함유하는 세포증식 촉진용 조성물 |
| CN113056286A (zh) | 2018-09-10 | 2021-06-29 | 冷泉港实验室 | 用于治疗胰腺炎的方法 |
| KR20200080179A (ko) * | 2018-12-26 | 2020-07-06 | 아미코젠주식회사 | 아세틸콜린 수용체 저해 펩타이드 및 이의 용도 |
| CN114929246A (zh) * | 2019-11-04 | 2022-08-19 | 法拉第制药公司 | 碘化物化合物用于治疗和预防化学疗法相关的恶病质和心脏毒性的用途 |
| AU2021231655B2 (en) | 2020-02-06 | 2024-02-15 | Austin Star Detonator Company | Integrated detonator sensors |
| WO2021245677A1 (en) * | 2020-06-05 | 2021-12-09 | Digestix Bioscience Inc. | Compositions and methods for treating dysplastic and early-stage neoplastic conditions |
| CN111863118B (zh) * | 2020-07-20 | 2023-09-05 | 湖南莱博赛医用机器人有限公司 | 基于tct制片进行tct和dna倍体分析的方法 |
| CN112557347B (zh) * | 2020-11-12 | 2023-10-24 | 渤海大学 | 一种黏液层中乳糜粒子迁移模型的制备及检测方法 |
| KR20240036634A (ko) * | 2021-07-23 | 2024-03-20 | 레터럴 아이피 피티와이 리미티드 | 란티오닌 합성효소 c-유사 단백질(lancl)에 결합할 수 있는 펩티드 조성물 및 그의 용도 |
| CN114606317B (zh) * | 2022-03-22 | 2022-12-02 | 中山大学附属第一医院 | 一种预测胃癌淋巴结转移的菌群标志物及其应用 |
| CN117106057A (zh) * | 2022-08-19 | 2023-11-24 | 南京汉欣医药科技有限公司 | 一种高纯的人促肾上腺皮质激素或其类似物及其规模化制备方法 |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1479268A (en) | 1973-07-05 | 1977-07-13 | Beecham Group Ltd | Pharmaceutical compositions |
| CH596313A5 (pt-PT) | 1975-05-30 | 1978-03-15 | Battelle Memorial Institute | |
| NO812612L (no) | 1980-08-06 | 1982-02-08 | Ferring Pharma Ltd | Enzym-inhibitorer. |
| US4414147A (en) | 1981-04-17 | 1983-11-08 | Massachusetts Institute Of Technology | Methods of decreasing the hydrophobicity of fibroblast and other interferons |
| US4558006A (en) | 1983-02-04 | 1985-12-10 | Kirin-Amgen, Inc. | A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| US5051448A (en) | 1984-07-24 | 1991-09-24 | The Mclean Hospital Corporation | GABA esters and GABA analog esters |
| US4704355A (en) | 1985-03-27 | 1987-11-03 | New Horizons Diagnostics Corporation | Assay utilizing ATP encapsulated within liposome particles |
| DE3676670D1 (de) | 1985-06-26 | 1991-02-07 | Cetus Corp | Solubilisierung von proteinen fuer pharmazeutische zusammensetzungen mittels polymerkonjugierung. |
| US4798824A (en) | 1985-10-03 | 1989-01-17 | Wisconsin Alumni Research Foundation | Perfusate for the preservation of organs |
| DE3924746A1 (de) | 1989-07-26 | 1991-01-31 | Behringwerke Ag | Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper |
| US6932968B1 (en) | 1989-07-26 | 2005-08-23 | Dade Behring Marburg Gmbh | Erythropoietin (EPO) peptides and antibodies directed against these |
| WO1991004014A1 (en) | 1989-09-21 | 1991-04-04 | Synergen, Inc. | Method for transporting compositions across the blood brain barrier |
| US5192746A (en) | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
| WO1994005332A2 (en) | 1992-09-01 | 1994-03-17 | Berlex Laboratories, Inc. | Glycolation of glycosylated macromolecules |
| US5559103A (en) | 1993-07-21 | 1996-09-24 | Cytel Corporation | Bivalent sialyl X saccharides |
| US5571787A (en) | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
| US5700909A (en) | 1993-07-30 | 1997-12-23 | The Regents Of The University Of California | Prosaposin and cytokine-derived peptides |
| WO1995021919A2 (en) | 1994-02-14 | 1995-08-17 | Kirin Brewery Company, Limited | Protein having tpo activity |
| US5576423A (en) | 1994-12-02 | 1996-11-19 | Schering Corporation | Antibodies to the slam protein expressed on activated T cells |
| US6849602B1 (en) | 1996-03-05 | 2005-02-01 | The Regents Of The University Of California | Compositions for alleviating neuropathic pain with prosaposin receptor agonists |
| US6271196B1 (en) | 1996-03-05 | 2001-08-07 | Regents Of The University Of Ca | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| US6346390B1 (en) | 1996-03-08 | 2002-02-12 | Receptron, Inc. | Receptor derived peptides involved in modulation of response to ligand binding |
| US5952293A (en) | 1996-03-08 | 1999-09-14 | Receptron | Receptor derived peptides involved in inhibition of receptor internalization in response to ligand binding |
| US5835382A (en) | 1996-04-26 | 1998-11-10 | The Scripps Research Institute | Small molecule mimetics of erythropoietin |
| US6437216B1 (en) | 1997-11-13 | 2002-08-20 | Interleukin Genetics Inc. | Transgenic models of inflammatory disease |
| IL124015A0 (en) | 1998-04-08 | 1999-01-26 | Yeda Res & Dev | Pharmaceutical compositions comprising a protein |
| US6307024B1 (en) * | 1999-03-09 | 2001-10-23 | Zymogenetics, Inc. | Cytokine zalpha11 Ligand |
| JP2003520194A (ja) | 1999-04-13 | 2003-07-02 | ザ ケネス エス．ウォーレン インスティテュート，インコーポレーテッド | 末梢投与したエリスロポエチンによる興奮組織機能のモジュレート |
| AU2001252650A1 (en) | 2000-04-28 | 2001-11-12 | Effector Cell Institute | Novel derivative of cell chemotactic factor |
| US7259146B2 (en) | 2000-05-26 | 2007-08-21 | Ortho-Mcneil Pharmaceutical, Inc. | Neuroprotective peptides |
| AU7490401A (en) * | 2000-05-26 | 2001-12-11 | Ortho Mcneil Pharm Inc | Neuroprotective peptides |
| US7432051B2 (en) | 2000-11-30 | 2008-10-07 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Erythropoietin and erythropoietin receptor expression in human cancer |
| US20030072737A1 (en) | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| PA8536201A1 (es) | 2000-12-29 | 2002-08-29 | Kenneth S Warren Inst Inc | Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina |
| US7205275B2 (en) | 2001-10-11 | 2007-04-17 | Amgen Inc. | Methods of treatment using specific binding agents of human angiopoietin-2 |
| CA2490411A1 (en) | 2002-06-28 | 2004-01-08 | Centocor, Inc. | Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| KR20060019501A (ko) * | 2002-07-01 | 2006-03-03 | 더 케네쓰 에스. 워렌 인스티튜트 인코포레이티드 | 응답 세포, 조직 및 기관을 보호, 회복 및 향상시키기위한 재조합 조직 보호 사이토카인 및 이를 코딩하는 핵산 |
| US7037902B2 (en) | 2002-07-03 | 2006-05-02 | Receptron, Inc. | Affinity small molecules for the EPO receptor |
| WO2005025606A1 (en) | 2003-09-09 | 2005-03-24 | Warren Pharmaceuticals, Inc. | Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
| JP2006511468A (ja) | 2002-09-09 | 2006-04-06 | ウォーレン ファーマシューティカルズ，インコーポレーテッド | 内因性エリスロポエチンの組織保護活性を維持する長期作用性エリスロポエチン |
| JP2004305006A (ja) | 2003-04-01 | 2004-11-04 | Japan Science & Technology Agency | 人工調製肺サーファクタント |
| US7718363B2 (en) | 2003-04-25 | 2010-05-18 | The Kenneth S. Warren Institute, Inc. | Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds |
| SI1629007T1 (sl) | 2003-05-12 | 2009-10-31 | Affymax Inc | Novi peptidi, ki se veĹľejo na eritropoetinski receptor |
| WO2005021579A2 (en) | 2003-08-28 | 2005-03-10 | Biorexis Pharmaceutical Corporation | Epo mimetic peptides and fusion proteins |
| EA010650B1 (ru) | 2003-09-29 | 2008-10-30 | Уоррен Фармасьютикалз, Инк. | Защищающие ткань цитокины для лечения и профилактики сепсиса и образования спаек |
| US20050090551A1 (en) * | 2003-10-27 | 2005-04-28 | Board Of Trustees Of Southern Illinois University | Therapeutic use of methionine for the treatment or prevention of mucositis |
| ME02251B (me) * | 2004-02-02 | 2015-12-31 | Engeneic Molecular Delivery Pty Ltd | Kompozicije i postupci in vitro i in vivo, ciljanog oslobađanja leka u ćelijama sisara, preko intaktnih minićelija izvedenih iz bakterija |
| US20080227696A1 (en) * | 2005-02-22 | 2008-09-18 | Biosurface Engineering Technologies, Inc. | Single branch heparin-binding growth factor analogs |
| ES2609084T3 (es) | 2004-03-16 | 2017-04-18 | Temple University - Of The Commonwealth System Of Higher Education | Derivados de fenoxi y feniltio sustituidos para tratar trastornos proliferativos |
| US20050267027A1 (en) | 2004-04-05 | 2005-12-01 | Lounsbury Karen M | Use of erythropoietin for treatment of cancer |
| WO2007010552A2 (en) * | 2005-03-17 | 2007-01-25 | Serum Institute Of India Limited | N- terminal peg conjugate of erythropoietin |
| WO2007052154A2 (en) | 2005-04-29 | 2007-05-10 | University Of Medicine And Dentistry Of New Jersey | Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators |
| US9345745B2 (en) | 2005-04-29 | 2016-05-24 | Bo Wang | Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides |
| EP2377884A1 (en) | 2005-05-10 | 2011-10-19 | Neoloch Aps | Neuritogenic peptides |
| EP1736481A1 (en) | 2005-05-13 | 2006-12-27 | Charite Universitätsmedizin-Berlin | Erythropoietin variants |
| EP1888098A2 (en) * | 2005-05-25 | 2008-02-20 | Neose Technologies, Inc. | Glycopegylated erythropoietin formulations |
| PT2371855E (pt) | 2005-08-05 | 2015-11-03 | Araim Pharmaceuticals Inc | Péptidos protetores de tecidos e suas utilizações |
| EP2121740A2 (en) | 2005-12-20 | 2009-11-25 | Copenhagen University | Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins |
| EP2120869A2 (en) | 2006-12-18 | 2009-11-25 | Altus Pharmaceuticals Inc. | Human growth hormone formulations |
| WO2009094172A2 (en) | 2008-01-22 | 2009-07-30 | Araim Pharmaceuticals, Inc. | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
-
2009
- 2009-01-22 WO PCT/US2009/000424 patent/WO2009094172A2/en active Application Filing
- 2009-01-22 KR KR1020187032456A patent/KR20180123731A/ko not_active Application Discontinuation
- 2009-01-22 NZ NZ587105A patent/NZ587105A/xx not_active IP Right Cessation
- 2009-01-22 EP EP09703197.5A patent/EP2245056B1/en active Active
- 2009-01-22 CA CA2712757A patent/CA2712757A1/en not_active Abandoned
- 2009-01-22 KR KR1020197020103A patent/KR20190085187A/ko not_active Application Discontinuation
- 2009-01-22 SG SG2013011762A patent/SG188161A1/en unknown
- 2009-01-22 NZ NZ601868A patent/NZ601868A/en not_active IP Right Cessation
- 2009-01-22 KR KR1020207017687A patent/KR20200075044A/ko not_active Application Discontinuation
- 2009-01-22 JP JP2010544332A patent/JP5542064B2/ja not_active Expired - Fee Related
- 2009-01-22 PL PL09703197T patent/PL2245056T4/pl unknown
- 2009-01-22 SG SG10201604530SA patent/SG10201604530SA/en unknown
- 2009-01-22 CN CN202010159339.1A patent/CN111346213A/zh active Pending
- 2009-01-22 US US12/863,973 patent/US8853358B2/en active Active
- 2009-01-22 NZ NZ621196A patent/NZ621196A/en not_active IP Right Cessation
- 2009-01-22 KR KR1020177011116A patent/KR101850908B1/ko active IP Right Grant
- 2009-01-22 CN CN200980110883.9A patent/CN102066413B/zh not_active Expired - Fee Related
- 2009-01-22 KR KR1020187010703A patent/KR20180041269A/ko not_active Application Discontinuation
- 2009-01-22 MX MX2010008050A patent/MX2010008050A/es active IP Right Grant
- 2009-01-22 MX MX2014004271A patent/MX356129B/es unknown
- 2009-01-22 EP EP15157182.5A patent/EP2933264A3/en not_active Withdrawn
- 2009-01-22 KR KR1020107018602A patent/KR101572286B1/ko active IP Right Grant
- 2009-01-22 CN CN201510002352.5A patent/CN104689298A/zh active Pending
- 2009-01-22 KR KR1020157033078A patent/KR101768792B1/ko active IP Right Grant
- 2009-01-22 CN CN201810587683.3A patent/CN108743916A/zh active Pending
- 2009-01-22 SG SG10202011946PA patent/SG10202011946PA/en unknown
- 2009-01-22 ES ES09703197.5T patent/ES2539124T3/es active Active
- 2009-01-22 AU AU2009206748A patent/AU2009206748B2/en not_active Ceased
-
2010
- 2010-07-22 IL IL207155A patent/IL207155A/en active IP Right Grant
- 2010-07-22 MX MX2019011592A patent/MX2019011592A/es unknown
- 2010-11-05 HK HK10110367.2A patent/HK1143822A1/xx not_active IP Right Cessation
-
2014
- 2014-05-02 JP JP2014094974A patent/JP6309815B2/ja not_active Expired - Fee Related
- 2014-09-30 US US14/502,735 patent/US9580465B2/en active Active
-
2016
- 2016-03-30 HK HK16103640.0A patent/HK1215713A1/zh unknown
- 2016-06-08 JP JP2016114592A patent/JP2017002040A/ja active Pending
-
2017
- 2017-01-30 US US15/419,963 patent/US20170232066A1/en not_active Abandoned
-
2019
- 2019-02-25 JP JP2019031123A patent/JP2019123715A/ja active Pending
- 2019-12-20 US US16/723,499 patent/US20200360476A1/en not_active Abandoned
-
2021
- 2021-02-04 JP JP2021016186A patent/JP2021073281A/ja active Pending